Acute Kidney Injury Treatment Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032

The global Acute Kidney Injury Treatment market size was estimated to be US$ 1.31 Billion in 2022 and is expected to grow at a CAGR of 7.4% between 2023 to 2032.

Acute kidney injury (AKI) treatment involves managing and treating the underlying cause of the injury and providing supportive care to prevent further damage to the kidneys. The treatment approach depends on the severity of the injury, underlying cause, and the patient's overall health. The primary goals of AKI treatment are to maintain fluid and electrolyte balance, manage complications, and prevent or treat infections. In some cases, hospitalization may be required for close monitoring and management of the condition.

Acute Kidney Injury Treatment Market Drivers

Rising healthcare expenditure globally is driving demand for AKI treatment

The global acute kidney injury (AKI) treatment market is driven by several factors, including the high incidence of chronic diseases, such as diabetes and hypertension, which are known to cause kidney damage. The growing prevalence of diabetes has led to an increase in AKI incidence, making AKI treatment an important focus area.

Furthermore, there is a growing demand for novel, effective, safe, and affordable AKI treatment options, driving innovation in the AKI treatment landscape, with companies investing heavily in research and development. Positive results from a Phase III clinical trial of Reltecimod, a novel immunomodulatory agent, for the treatment of AKI, demonstrate the potential of such treatments.

Moreover, rising healthcare expenditure globally is driving demand for AKI treatment options, as governments, insurance providers, and patients are willing to invest more in healthcare to improve outcomes and reduce the risk of complications. For instance, in India, the government launched the Ayushman Bharat program in 2018, which aims to provide healthcare coverage to around 500 million people, including those with chronic kidney disease.

These factors are interdependent and have a significant impact on the AKI treatment market. Therefore, it is crucial for companies to continue to focus on developing new and innovative AKI treatments to address the growing demand and unmet medical needs.

Treatment Type Segmentation of Global Acute Kidney Injury Treatment Market

Dialysis is the largest segment in the AKI treatment market

Based on treatment type, dialysis is the largest segment in the global acute kidney injury (AKI) treatment market. This is primarily due to the severe nature of AKI cases that require immediate and aggressive treatment, and dialysis is often the most effective and rapid way to remove waste products and excess fluids from the blood when the kidneys are not functioning properly. Dialysis involves the use of a machine to filter the blood, and it can be performed in different ways, including hemodialysis and peritoneal dialysis.

Hemodialysis is the most commonly used method, and it involves the use of an artificial kidney machine to filter the blood outside the body. Peritoneal dialysis, on the other hand, involves the use of the peritoneum, a membrane lining the abdominal cavity, to filter the blood.

While medications are also an important component of AKI treatment, they are often used in conjunction with dialysis or other supportive measures. Medications may be used to manage the underlying cause of AKI, such as antibiotics for infections or diuretics to help remove excess fluid. However, they may not be sufficient to manage the severe complications associated with AKI, such as fluid overload, hyperkalemia, and metabolic acidosis, which require prompt and aggressive treatment with dialysis.

Regional Trends of the Global Acute Kidney Injury Treatment Market

North America dominates the global AKI treatment market

Geographically, the global acute kidney injury treatment market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.

Following are some of the major trends in these regions –

North America: North America dominates the global AKI treatment market, owing to the presence of advanced healthcare infrastructure, high healthcare spending, and a growing geriatric population. The United States is the largest market in this region, driven by the high incidence of chronic kidney diseases and rising demand for dialysis.

Europe: Europe is the second-largest market for AKI treatment, driven by the high prevalence of diabetes, hypertension, and cardiovascular diseases, which are major risk factors for AKI. The United Kingdom, Germany, and France are the largest markets in this region, with a high demand for dialysis treatment.

Asia-Pacific: The Asia-Pacific region is expected to witness significant growth in the AKI treatment market due to the large population base, rising healthcare spending, and growing prevalence of chronic diseases. China, India, and Japan are the largest markets in this region, with a high demand for dialysis treatment.

Middle East and Africa: The MEA region is a growing market for AKI treatment, driven by the rising incidence of chronic kidney diseases and the improving healthcare infrastructure in countries such as Saudi Arabia, the United Arab Emirates, and South Africa.

South America: The South American market for AKI treatment is driven by the growing geriatric population and the high prevalence of chronic diseases such as diabetes and hypertension. Brazil and Argentina are the largest markets in this region, with a high demand for dialysis treatment.

Key players and market strategies:

Companies operating in the global acute kidney injury (AKI) treatment market are adopting various growth strategies to expand their market presence and gain a competitive edge.

Here are some major growth strategies that these companies are adopting:

Product launches: Companies are launching new products to expand their portfolio of AKI treatment options. For example, in 2020, Baxter International Inc. launched AK 98, a new hemodialysis machine with advanced features for the treatment of AKI.

Strategic collaborations and partnerships: Companies are forming strategic collaborations and partnerships with other companies or academic institutions to develop and commercialize new AKI treatment options. For example, in 2019, Sanofi and Microbiotix, Inc. entered into a collaboration to develop a novel treatment for AKI.

Merger and acquisition: Companies are acquiring other companies to expand their AKI treatment portfolio and gain a larger market share. For example, in 2021, Fresenius Medical Care AG & Co. KGaA acquired NxStage Medical, Inc., a provider of home dialysis products and services.

Geographic expansion: Companies are expanding their geographic presence by entering new markets or expanding their existing presence in emerging markets. For example, in 2019, B. Braun Melsungen AG expanded its business in India by setting up a new production facility for medical devices, including AKI treatment products.

Research and development: Companies are investing heavily in research and development to develop innovative AKI treatment options with better efficacy and safety. For example, in 2020, AstraZeneca Plc announced a collaboration with Kidney Research UK to develop new treatment options for AKI.

AMAG Pharmaceuticals, Inc., AstraZeneca, Baxter International Inc., B. Braun Melsungen AG, BioPorto Diagnostics A/S, Fresenius Medical Care AG & Co. KGaA, GlaxoSmithKline plc, Johnson & Johnson, Medtronic plc, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Terumo Corporation and many more.

Global Acute Kidney Injury Treatment Market Segmentation:

By Treatment Type:

• Dialysis
• Medications

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region

• North America
  • United States
  • Canada
  • Rest of North America
• Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  
  • Japan
  • India
  • China
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East & Africa
  •  UAE
  • Saudi Arabia
  • South Africa
  • Rest of the Middle East & Africa
• South America
  • Brazil
  • Rest of South America

1. Introduction
   • Research Objectives
   • Report Assumptions
   • Research Methodology
   • Abbreviations
2. Preface
   • Market Definition
   • Report Scope and Market Segmentation
   • Research Highlights
3. Market Synopsis: Global Acute Kidney Injury Treatment Market
4. Global Acute Kidney Injury Treatment Market Qualitative Analysis
   • Trends
     • Market trends
     • Technology Trends
   • PESTLE Analysis (For 3 prominent countries)
   • Market Influencers
     • Driving Forces
     • Hindering Forces
     • Opportunities
   • COVID-19 impact
   • Porter’s Five Forces Analysis
   • Value Chain Analysis
5. Global Acute Kidney Injury Treatment Market Analysis and Forecast, by Treatment Type
   • Overview and definitions
   • Key segment analysis
   • Global Acute Kidney Injury Treatment Market Estimates (US$ Mn), Treatment Type, 2019 – 2032
     • Dialysis
     • Medications

6. Global Acute Kidney Injury Treatment Market Analysis and Forecast, by Injury Type
   • Overview and definitions
   • Key segment analysis
   • Global Acute Kidney Injury Treatment Market Estimates (US$ Mn), Injury Type, 2019 – 2032
     • Pre-renal Acute Kidney Injury
     • Intrinsic Renal Acute Kidney Injury
     • Post-renal Acute Kidney Injury

7. Global Acute Kidney Injury Treatment Market Analysis and Forecast, by End Use
   • Overview and definitions
   • Key segment analysis
   • Global Acute Kidney Injury Treatment Market Estimates (US$ Mn), End Use, 2019 – 2032
     • Hospitals
     • Ambulatory Surgical Centers
     • Others

8. Global Acute Kidney Injury Treatment Market Analysis and Forecast, by Region
   • Overview and definitions
   • Key segment analysis
   • Global Acute Kidney Injury Treatment Market Estimates (US$ Mn), by Region, 2019 – 2032
     • North America
     • Europe
     • Asia Pacific
     • Middle East & Africa
     • South America

9. North America Acute Kidney Injury Treatment Market Analysis and Forecast
   • Overview and definitions
   • Key segment analysis
   • North America Acute Kidney Injury Treatment Market Estimates (US$ Mn), Treatment Type, 2019 – 2032
     • Dialysis
     • Medications
   • North America Acute Kidney Injury Treatment Market Estimates (US$ Mn), Injury Type, 2019 – 2032
     • Pre-renal Acute Kidney Injury
     • Intrinsic Renal Acute Kidney Injury
     • Post-renal Acute Kidney Injury
   • North America Acute Kidney Injury Treatment Market Estimates (US$ Mn), End Use, 2019 – 2032
     • Hospitals
     • Ambulatory Surgical Centers
     • Others
   • North America Acute Kidney Injury Treatment Market Estimates (US$ Mn), by Country, 2019 – 2032
     • United States
     • Canada
     • Rest of North America

10. Europe Acute Kidney Injury Treatment Market Analysis and Forecast
    • Overview and definitions
    • Key segment analysis
    • Europe Acute Kidney Injury Treatment Market Estimates (US$ Mn), Treatment Type, 2019 – 2032
      • Dialysis
      • Medications
    • Europe Acute Kidney Injury Treatment Market Estimates (US$ Mn), Injury Type, 2019 – 2032
      • Pre-renal Acute Kidney Injury
      • Intrinsic Renal Acute Kidney Injury
      • Post-renal Acute Kidney Injury
    • Europe Acute Kidney Injury Treatment Market Estimates (US$ Mn), End Use, 2019 – 2032
      • Hospitals
      • Ambulatory Surgical Centers
      • Others
    • Europe Acute Kidney Injury Treatment Market Estimates (US$ Mn), by Country, 2019 – 2032
      • Germany
      • United Kingdom
      • Italy
      • France
      • Spain
      • Rest of Europe

11. Asia Pacific Acute Kidney Injury Treatment Market Analysis and Forecast
    • Overview and definitions
    • Key segment analysis
    • Asia Pacific Acute Kidney Injury Treatment Market Estimates (US$ Mn), Treatment Type, 2019 – 2032
      • Dialysis
      • Medications
    • Asia Pacific Acute Kidney Injury Treatment Market Estimates (US$ Mn), Injury Type, 2019 – 2032
      • Pre-renal Acute Kidney Injury
      • Intrinsic Renal Acute Kidney Injury
      • Post-renal Acute Kidney Injury
    • Asia Pacific Acute Kidney Injury Treatment Market Estimates (US$ Mn), End Use, 2019 – 2032
      • Hospitals
      • Ambulatory Surgical Centers
      • Others
    • Asia Pacific Acute Kidney Injury Treatment Market Estimates (US$ Mn), by Country, 2019 – 2032
      • China
      • Japan
      • South Korea
      • India
      • Australia
      • Rest of Asia Pacific

12. Middle East & Africa Acute Kidney Injury Treatment Market Analysis and Forecast
    • Overview and definitions
    • Key segment analysis
    • Middle East & Africa Acute Kidney Injury Treatment Market Estimates (US$ Mn), Treatment Type, 2019 – 2032
      • Dialysis
      • Medications
    • Middle East & Africa Acute Kidney Injury Treatment Market Estimates (US$ Mn), Injury Type, 2019 – 2032
      • Pre-renal Acute Kidney Injury
      • Intrinsic Renal Acute Kidney Injury
      • Post-renal Acute Kidney Injury
    • Middle East & Africa Acute Kidney Injury Treatment Market Estimates (US$ Mn), End Use, 2019 – 2032
      • Hospitals
      • Ambulatory Surgical Centers
      • Others
    • Middle East & Africa Acute Kidney Injury Treatment Market Estimates (US$ Mn), by Country, 2019 – 2032
      • UAE
      • Saudi Arabia
      • South Africa
      • Rest of MEA

13. South America Acute Kidney Injury Treatment Market Analysis and Forecast
    • Overview and definitions
    • Key segment analysis
    • South America Acute Kidney Injury Treatment Market Estimates (US$ Mn), Treatment Type, 2019 – 2032
      • Dialysis
      • Medications
    • South America Acute Kidney Injury Treatment Market Estimates (US$ Mn), Injury Type, 2019 – 2032
      • Pre-renal Acute Kidney Injury
      • Intrinsic Renal Acute Kidney Injury
      • Post-renal Acute Kidney Injury
    • South America Acute Kidney Injury Treatment Market Estimates (US$ Mn), End Use, 2019 – 2032
      • Hospitals
      • Ambulatory Surgical Centers
      • Others
    • South America Acute Kidney Injury Treatment Market Estimates (US$ Mn), by Country, 2019 – 2032
      • Brazil
      • Argentina
      • Rest of South America

14. Competition Analysis – Global Acute Kidney Injury Treatment Market
    • Market Composition
    • Market Share Analysis (%), by Supplier (2022)
    • Company Profiles
      • AMAG Pharmaceuticals, Inc.
        • Business overview
        • Geographic presence
        • Product portfolio
        • Financial facts
        • Relevant news and strategic view
      • AstraZeneca
      • Baxter International Inc.
      • Braun Melsungen AG
      • BioPorto Diagnostics A/S
      • Fresenius Medical Care AG & Co. KGaA
      • GlaxoSmithKline plc
      • Johnson & Johnson
      • Medtronic plc
      • Merck & Co., Inc.
      • Novartis AG
      • Pfizer Inc.
      • Sanofi
      • Teva Pharmaceutical Industries Ltd.
      • Terumo Corporation

15. Conclusion & Recommendations